Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583.
Uterine rupture among women with a prior cesarean delivery.
Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis.
Time-resolved x-ray crystallography of heme proteins.
Role of MicroRNAs in NAFLD/NASH.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Role of MicroRNAs in NAFLD/NASH.
Szabo G, Csak T. Role of MicroRNAs in NAFLD/NASH. Dig Dis Sci. 2016 May; 61(5):1314-24.
View in:
PubMed
subject areas
Biomarkers
Fatty Liver
Gene Expression Regulation
Humans
Metabolic Syndrome
MicroRNAs
Non-alcoholic Fatty Liver Disease
authors with profiles
Gyongyi Szabo MD, PhD